Cascadian Therapeutics, Inc.

CIK 1412067 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cascadian Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 11, 2019CT ORDER9999999997-19-002777
May 22, 2018CT ORDER9999999997-18-005814
Apr 9, 2018SC 13G/A0001140361-18-017853
Mar 22, 201815-12B0001193125-18-091899
Mar 21, 2018EFFECT9999999995-18-000643
Mar 21, 2018EFFECT9999999995-18-000642
Mar 21, 2018EFFECT9999999995-18-000638
Mar 21, 2018EFFECT9999999995-18-000640
Mar 19, 2018SC 13D/A0001072613-18-000224
Mar 13, 201840001209191-18-019369
Mar 13, 201840001209191-18-019376
Mar 13, 201840001209191-18-019375
Mar 13, 201840000899243-18-007292
Mar 13, 201840000899243-18-007300
Mar 13, 201840000899243-18-007306
Mar 13, 201840000899243-18-007301
Mar 13, 201840001209191-18-019372
Mar 13, 201840000899243-18-007294
Mar 13, 201840000899243-18-007302
Mar 13, 201840000899243-18-007303
Mar 13, 201840001209191-18-019368
Mar 13, 201840000899243-18-007310
Mar 13, 201840000899243-18-007308
Mar 13, 201840001209191-18-019378
Mar 13, 201840001209191-18-019374